Our guest is Dr. Kristen Scarpato, a urologic oncologist at Vanderbilt University Medical Center in Nashville, TN. She is here to talk with us about Androgen Deprivation Therapy, or ADT, for prostate cancer. She covers information such as what is ADT, questions to ask your doctor and what to expect after treatment.
Short on time? Use the below timestamps to jump to any topic section:
0:48 - Introduction
2:10 - Prostate cancer overview
3:30 - What is Androgren Deprivation Therapy (ADT)?
4:30 - Why is ADT important?
6:43 - When during treatment would ADT be considered?
9:32 - What patients benefit the most from ADT?
10:45 - What administers ADT?
12:10 - What can patients expect after ADT?
15:30 - Talking with your doctor
17:16 - Final thoughts
Supported by an independent educational grant provided by Myovant Sciences LTD and Pfizer Inc.
For more information, please subscribe to our free digital magazine, UrologyHealth extra.
December 1, 2022
Share Your Story
Have a story to share? The Urology Care Foundation invites you to share your experience with a urologic condition and how it has affected you or your family.